These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 24064566

  • 1. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F, Qu X, Fan Q, Wang L, Tang T, Hao Y, Dai K.
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [Abstract] [Full Text] [Related]

  • 2. Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates.
    Thiele S, Rauner M, Goettsch C, Rachner TD, Benad P, Fuessel S, Erdmann K, Hamann C, Baretton GB, Wirth MP, Jakob F, Hofbauer LC.
    J Cell Biochem; 2011 Jun; 112(6):1593-600. PubMed ID: 21344486
    [Abstract] [Full Text] [Related]

  • 3. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M, Donofrio G, Storti P, Guasco D, Toscani D, Lazzaretti M, Bonomini S, Agnelli L, Capocefalo A, Dalla Palma B, Neri A, Nicolini F, Lisignoli G, Russo F, Colla S, Aversa F, Giuliani N.
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [Abstract] [Full Text] [Related]

  • 4. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R.
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [Abstract] [Full Text] [Related]

  • 5. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G.
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [Abstract] [Full Text] [Related]

  • 6. WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.
    Thiele S, Göbel A, Rachner TD, Fuessel S, Froehner M, Muders MH, Baretton GB, Bernhardt R, Jakob F, Glüer CC, Bornhäuser M, Rauner M, Hofbauer LC.
    J Bone Miner Res; 2015 Mar; 30(3):471-80. PubMed ID: 25224731
    [Abstract] [Full Text] [Related]

  • 7. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
    Zhu Y, Shen T, Liu J, Zheng J, Zhang Y, Xu R, Sun C, Du J, Chen Y, Gu L.
    Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
    [Abstract] [Full Text] [Related]

  • 8. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, Minami Y.
    Oncogene; 2009 Sep 10; 28(36):3197-208. PubMed ID: 19561643
    [Abstract] [Full Text] [Related]

  • 9. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.
    Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A.
    Oncogene; 2010 Apr 08; 29(14):2036-46. PubMed ID: 20101234
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W, Wang L, Mizokami A, Shi J, Zou C, Dai J, Keller ET, Lu Y, Zhang J.
    Chin J Cancer; 2017 Mar 29; 36(1):35. PubMed ID: 28356132
    [Abstract] [Full Text] [Related]

  • 11. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
    Jin Z, Zhao C, Han X, Han Y.
    BMC Cancer; 2012 Oct 18; 12():480. PubMed ID: 23075330
    [Abstract] [Full Text] [Related]

  • 12. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP, Miller RE, Jones JC, Zhang J, Keller ET, Dougall WC.
    Prostate; 2008 Jan 01; 68(1):92-104. PubMed ID: 18008334
    [Abstract] [Full Text] [Related]

  • 13. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
    Liu J, Zhang Y, Xu R, Du J, Hu Z, Yang L, Chen Y, Zhu Y, Gu L.
    Cell Signal; 2013 Feb 01; 25(2):447-56. PubMed ID: 23123500
    [Abstract] [Full Text] [Related]

  • 14. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
    Tate A, Isotani S, Bradley MJ, Sikes RA, Davis R, Chung LW, Edlund M.
    BMC Cancer; 2006 Jul 25; 6():197. PubMed ID: 16869958
    [Abstract] [Full Text] [Related]

  • 15. Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
    Angelucci A, Gravina GL, Rucci N, Millimaggi D, Festuccia C, Muzi P, Teti A, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2006 Mar 25; 13(1):197-210. PubMed ID: 16601288
    [Abstract] [Full Text] [Related]

  • 16. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K.
    Mol Cancer; 2014 Apr 26; 13():88. PubMed ID: 24766647
    [Abstract] [Full Text] [Related]

  • 17. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer.
    Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, Thrasivoulou C, Masters JR, Ahmed A.
    PLoS One; 2010 May 04; 5(5):e10456. PubMed ID: 20454608
    [Abstract] [Full Text] [Related]

  • 18. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
    Jayakumar S, Kunwar A, Sandur SK, Pandey BN, Chaubey RC.
    Biochim Biophys Acta; 2014 Jan 04; 1840(1):485-94. PubMed ID: 24121106
    [Abstract] [Full Text] [Related]

  • 19. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
    Borghese C, Cattaruzza L, Pivetta E, Normanno N, De Luca A, Mazzucato M, Celegato M, Colombatti A, Aldinucci D.
    J Cell Biochem; 2013 May 04; 114(5):1135-44. PubMed ID: 23192362
    [Abstract] [Full Text] [Related]

  • 20. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS, Millena AC, Khan SA.
    Prostate; 2017 Jan 04; 77(1):72-81. PubMed ID: 27604827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.